Cargando…

Intestinal microbiota: A promising therapeutic target for hypertension

Hypertension has developed into an escalating serious global public health problem with multiple and unclear pathophysiological mechanisms. Recent studies have identified intestinal microbiota as a key perpetrator of hypertension through a variety of mechanisms. In this review, we highlight the pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Dating, Xiang, Hui, Yan, Jiangtao, He, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705378/ https://www.ncbi.nlm.nih.gov/pubmed/36457803 http://dx.doi.org/10.3389/fcvm.2022.970036

Ejemplares similares

mRNA, lncRNA, and circRNA expression profiles in a new aortic dissection murine model induced by hypoxia and Ang II
por: Li, Yuanyuan, et al.
Publicado: (2022)

Piezo1 in vascular remodeling of atherosclerosis and pulmonary arterial hypertension: A potential therapeutic target
por: Xu, Han, et al.
Publicado: (2022)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
por: Xiang, Hui, et al.
Publicado: (2022)

Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research
por: Mamazhakypov, Argen, et al.
Publicado: (2023)

The Association of Morning Hypertension With Target Organ Damage in Patients With Chronic Kidney Disease and Hypertension
por: Liu, Xiang, et al.
Publicado: (2021)

Promising Therapeutic Candidate for Myocardial Ischemia/Reperfusion Injury: What Are the Possible Mechanisms and Roles of Phytochemicals?
por: Chen, Cong, et al.
Publicado: (2022)

Aortic Coarctation Associated With Hypertrophic Cardiomyopathy in a Woman With Hypertension and Syncope: A Case Report With 8-Year Follow-Up
por: Yang, Hong, et al.
Publicado: (2022)

Liuzijue training improves hypertension and modulates gut microbiota profile
por: Wu, Sha, et al.
Publicado: (2023)

Gut Microbiota Dysbiosis in Human Hypertension: A Systematic Review of Observational Studies
por: Guo, Yang, et al.
Publicado: (2021)

Targets of statins intervention in LDL-C metabolism: Gut microbiota
por: Sun, ChangXin, et al.
Publicado: (2022)

Comparison of Influence of Blood Pressure and Carotid-Femoral Pulse Wave Velocity on Target Organ Damage in Hypertension
por: Chao, Huijuan, et al.
Publicado: (2022)

Effects of oral targeted treatments in pulmonary arterial hypertension: A systematic review and meta-analysis
por: Zhu, Hui-ru, et al.
Publicado: (2022)

Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
por: Jing, Lele, et al.
Publicado: (2022)

Yes-Associated Protein in Atherosclerosis and Related Complications: A Potential Therapeutic Target That Requires Further Exploration
por: Sun, Congrui, et al.
Publicado: (2021)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
por: Peh, Zhen Hui, et al.
Publicado: (2023)

Integrative Bioinformatics Approaches for Identification of Drug Targets in Hypertension
por: Hemerich, Daiane, et al.
Publicado: (2018)

Influence of hypertension duration and blood pressure levels on cardiovascular disease and all-cause mortality: A large prospective cohort study
por: Zheng, Yan, et al.
Publicado: (2022)

Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential
por: Körbelin, Jakob, et al.
Publicado: (2023)

The therapeutic concordance approach reduces adverse drug reactions in patients with resistant hypertension
por: Trimarco, Valentina, et al.
Publicado: (2023)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

Intestinal Microbiota—A Promising Target for Antiviral Therapy?
por: Yang, Mengling, et al.
Publicado: (2021)

Gut immune cells—A novel therapeutical target for cardiovascular disease?
por: Ganesh, Naresh, et al.
Publicado: (2022)

SUMOylation as a Therapeutic Target for Myocardial Infarction
por: Zhao, Wei, et al.
Publicado: (2021)

Trends in exercise for hypertension: a bibliometric analysis
por: Lou, Yan, et al.
Publicado: (2023)

Identifying Excessive Intake of Oil and Salt to Prevent and Control Hypertension: A Latent Class Analysis
por: He, Lu, et al.
Publicado: (2022)

Histone Deacetylases in the Inflamed Intestinal Epithelium—Promises of New Therapeutic Strategies
por: Gerbeth, Lorenz, et al.
Publicado: (2021)

The interstitial compartment as a therapeutic target in heart failure
por: Aronson, Doron
Publicado: (2022)

Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases
por: Zou, Yifei, et al.
Publicado: (2023)

AMPK: Potential Therapeutic Target for Vascular Calcification
por: Lu, Yi, et al.
Publicado: (2021)

Editorial: The molecular mechanisms and therapeutic targets of atherosclerosis
por: Gualtierotti, Roberta, et al.
Publicado: (2023)

Identification of biomarkers, pathways and potential therapeutic agents for salt-sensitive hypertension using RNA-seq
por: Chao, Xiaoying, et al.
Publicado: (2022)

Association Between Serum Calcium and the Prevalence of Hypertension Among US Adults
por: Hua, Yang, et al.
Publicado: (2021)

Effect of exercise on vascular function in hypertension patients: A meta-analysis of randomized controlled trials
por: Zhou, Huayi, et al.
Publicado: (2022)

The promise of pulsed field ablation and the challenges ahead
por: Iyengar, Shruti Krishna, et al.
Publicado: (2023)

The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders
por: Milusev, Anastasia, et al.
Publicado: (2022)

Serpins in Hemostasis as Therapeutic Targets for Bleeding or Thrombotic Disorders
por: Bianchini, Elsa P., et al.
Publicado: (2021)

Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
por: Ye, Wen-Chu, et al.
Publicado: (2021)

Mitochondrial Dynamics: Pathogenesis and Therapeutic Targets of Vascular Diseases
por: Luan, Yi, et al.
Publicado: (2021)

Effects of Intermittent Compared With Continuous Energy Restriction on Blood Pressure Control in Overweight and Obese Patients With Hypertension
por: He, Chao-Jie, et al.
Publicado: (2021)

Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target
por: Li, Junyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4s53pmmcdicoppm968pcf18bbh